Literature DB >> 10864477

Lysophosphatidic acid stimulates intestinal restitution via cytoskeletal activation and remodeling.

O J Hines1, N Ryder, J Chu, D McFadden.   

Abstract

BACKGROUND: The gastrointestinal tract heals superficial wounds by a process of epithelial migration termed restitution. Restitution is an important response for preventing conditions like stress gastritis, ulcer disease, celiac sprue, ischemia-reperfusion injury, bacterial translocation during shock, and inflammatory bowel disease. The purpose of this study was to determine the effect of a platelet product, lysophosphatidic acid (LPA), on intestinal restitution.
MATERIALS AND METHODS: IEC-6 cells were used to study the effect of LPA on intracellular calcium mobilization, actin stress fiber formation, and actin and FAK protein levels. An in vitro model of restitution was utilized to determine the LPA-stimulated IEC-6 migration.
RESULTS: LPA administration stimulated intracellular calcium mobilization in a dose-dependent fashion with typical peak and plateau phases suggestive of a receptor-mediated response. Actin stress fiber formation occurred within 15 min after LPA treatment and was especially apparent at 2 h. This response was accompanied by higher actin and FAK protein levels. LPA also stimulated IEC-6 migration 3-fold within 24 h. All of these effects were completely inhibited by pertussis toxin.
CONCLUSIONS: Exposure of IEC-6 cells to LPA results in significant calcium mobilization and cytoskeletal remodeling within minutes. This activity is accompanied by increased actin and FAK levels. Cellular migration is significantly enhanced by LPA. These responses seem to be due to pertussis-sensitive G-protein-associated receptors. The ability of LPA to potentiate intestinal cell restitution appears, in part, to be mediated by effects on intestinal cell cytoskeletal structure. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864477     DOI: 10.1006/jsre.2000.5941

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  19 in total

1.  Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity.

Authors:  Juliette Mazereeuw-Hautier; Sandra Gres; Madie Fanguin; Clotilde Cariven; Josette Fauvel; Bertrand Perret; Hugues Chap; Jean-Pierre Salles; Jean-Sébastien Saulnier-Blache
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

2.  Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia.

Authors:  Rebecca A Moyer; Michael K Wendt; Priscilla A Johanesen; Jerrold R Turner; Michael B Dwinell
Journal:  Lab Invest       Date:  2007-06-18       Impact factor: 5.662

3.  Enteric glia promote intestinal mucosal healing via activation of focal adhesion kinase and release of proEGF.

Authors:  Laurianne Van Landeghem; Julien Chevalier; Maxime M Mahé; Thilo Wedel; Petri Urvil; Pascal Derkinderen; Tor Savidge; Michel Neunlist
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

Review 4.  Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury.

Authors:  Emily Archer Slone; Sherry D Fleming
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

5.  Src-mediated caveolin-1 phosphorylation regulates intestinal epithelial restitution by altering Ca(2+) influx after wounding.

Authors:  Navneeta Rathor; Ran Zhuang; Jian-Ying Wang; James M Donahue; Douglas J Turner; Jaladanki N Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-02-20       Impact factor: 4.052

Review 6.  Progress in researches about focal adhesion kinase in gastrointestinal tract.

Authors:  Hui-Fang Hao; Yoshio Naomoto; Xiao-Hong Bao; Nobuyuki Watanabe; Kazufumi Sakurama; Kazuhiro Noma; Yasuko Tomono; Takuya Fukazawa; Yasuhiro Shirakawa; Tomoki Yamatsuji; Junji Matsuoka; Munenori Takaoka
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

7.  The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury.

Authors:  Wenlin Deng; E Shuyu; Ryoko Tsukahara; William J Valentine; Gangadhar Durgam; Veeresa Gududuru; Louisa Balazs; Venkatraman Manickam; Marcello Arsura; Lester VanMiddlesworth; Leonard R Johnson; Abby L Parrill; Duane D Miller; Gabor Tigyi
Journal:  Gastroenterology       Date:  2007-03-24       Impact factor: 22.682

8.  RhoA enhances store-operated Ca2+ entry and intestinal epithelial restitution by interacting with TRPC1 after wounding.

Authors:  Hee Kyoung Chung; Navneeta Rathor; Shelley R Wang; Jian-Ying Wang; Jaladanki N Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-03       Impact factor: 4.052

9.  Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation.

Authors:  Bart de Vries; Robert A Matthijsen; Annemarie A J H M van Bijnen; Tim G A M Wolfs; Wim A Buurman
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

10.  Submucosal connective tissue-type mast cells contribute to the production of lysophosphatidic acid (LPA) in the gastrointestinal tract through the secretion of autotaxin (ATX)/lysophospholipase D (lysoPLD).

Authors:  Ken Mori; Joji Kitayama; Junken Aoki; Yasuhiro Kishi; Dai Shida; Hiroharu Yamashita; Hiroyuki Arai; Hirokazu Nagawa
Journal:  Virchows Arch       Date:  2007-06-07       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.